- Home
- DNN vs CLDX Comparison
DNN vs CLDX Comparison
Compare DNN & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- CLDX
- Stock Information
- Founded
- DNN 1936
- CLDX 1983
- Country
- DNN Canada
- CLDX United States
- Employees
- DNN N/A
- CLDX N/A
- Industry
- DNN Other Metals and Minerals
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DNN Basic Materials
- CLDX Health Care
- Exchange
- DNN Nasdaq
- CLDX Nasdaq
- Market Cap
- DNN 1.8B
- CLDX 1.8B
- IPO Year
- DNN 1997
- CLDX 2008
- Fundamental
- Price
- DNN $1.90
- CLDX $25.65
- Analyst Decision
- DNN Strong Buy
- CLDX Buy
- Analyst Count
- DNN 2
- CLDX 7
- Target Price
- DNN $3.00
- CLDX $64.83
- AVG Volume (30 Days)
- DNN 19.7M
- CLDX 914.2K
- Earning Date
- DNN 11-07-2024
- CLDX 02-24-2025
- Dividend Yield
- DNN N/A
- CLDX N/A
- EPS Growth
- DNN N/A
- CLDX N/A
- EPS
- DNN N/A
- CLDX N/A
- Revenue
- DNN $2,920,167.00
- CLDX $9,976,000.00
- Revenue This Year
- DNN $272.08
- CLDX N/A
- Revenue Next Year
- DNN $77.80
- CLDX N/A
- P/E Ratio
- DNN N/A
- CLDX N/A
- Revenue Growth
- DNN N/A
- CLDX 128.55
- 52 Week Low
- DNN $1.40
- CLDX $22.93
- 52 Week High
- DNN $2.47
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- DNN 36.53
- CLDX 46.74
- Support Level
- DNN $1.88
- CLDX $24.14
- Resistance Level
- DNN $1.96
- CLDX $25.95
- Average True Range (ATR)
- DNN 0.09
- CLDX 1.28
- MACD
- DNN -0.04
- CLDX -0.03
- Stochastic Oscillator
- DNN 5.72
- CLDX 45.00
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company with interests focused in the Athabasca Basin region of northern Saskatchewan, Canada. The company has an effective 95% interest in its flagship Wheeler River Uranium Project, which is the largest undeveloped uranium project in the infrastructure-rich eastern portion of the Athabasca Basin region of northern Saskatchewan. The company is also engaged in mine decommissioning and environmental services through its Closed Mines group, which manages its Elliot Lake reclamation projects and provides third-party post-closure mine care and maintenance services.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.